Grant: Banting Postdoctoral Fellowship Program
University of Toronto
$140,000.00
Unraveling the molecular networks of DNA double-strand break repair pathway choice
EF 2014-15
Résumé
Our cells are constantly challenged by breaks in both strands of the DNA double helix (DNA double-strand breaks, DSBs). Whether DSBs arise due to external factors such as radiation and genome-damaging chemicals, occur as byproducts of cellular metabolism or are generated physiologically as part of normal development, faithful repair of the breaks is instrumental to cell survival. Cells therefore have multiple DSB repair mechanisms at their disposal. However, different mechanisms are fit to properly repair DSBs arising in different contexts and failure to choose the most appropriate DSB repair pathway can cause detrimental genome instability, which underlies severe developmental disorders and is a major driver of tumorigenesis. On the other hand, genome instability arising due to improper DSB repair pathway choice can be exploited clinically, because it sensitizes some types of hereditary breast and ovarian cancer cells to treatment with PARP inhibitors (PARPi), which are next generation chemotherapeutic drugs. Still, despite its importance for genome stability and potential clinical impact, we know very little about how DSB repair pathway choice is executed. The goal of my research project in the Durocher lab at the Lunenfeld-Tanenbaum Research Institute is therefore to explore how cells choose between DSB repair pathways on the molecular level. Modern functional genomic approaches implemented in collaboration with other accomplished scientists in Toronto's research institutions will be used to screen among thousands of genes, in cultured human cells, for novel factors involved in DSB repair pathway choice. The factors will be identified based on a simple strategy that uses sensitivity to PARPi as readout. We will then characterize the biological functions of the newly identified factors to establish the molecular details of DSB repair pathway choice, expanding the understanding of how genome stability is regulated in normal as well as malignant cells.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
317418
Name
Zimmermann Michal
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Unraveling the molecular networks of DNA double-strand break repair pathway choice
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Crispr; Dna Repair; Double-Strand Break; Functional Genomics; Homologous Recombination; Non-Homologous End Joining; Parp Inhibitor; Repair Pathway Choice
Abstract
Our cells are constantly challenged by breaks in both strands of the DNA double helix (DNA double-strand breaks, DSBs). Whether DSBs arise due to external factors such as radiation and genome-damaging chemicals, occur as byproducts of cellular metabolism or are generated physiologically as part of normal development, faithful repair of the breaks is instrumental to cell survival. Cells therefore have multiple DSB repair mechanisms at their disposal. However, different mechanisms are fit to properly repair DSBs arising in different contexts and failure to choose the most appropriate DSB repair pathway can cause detrimental genome instability, which underlies severe developmental disorders and is a major driver of tumorigenesis. On the other hand, genome instability arising due to improper DSB repair pathway choice can be exploited clinically, because it sensitizes some types of hereditary breast and ovarian cancer cells to treatment with PARP inhibitors (PARPi), which are next generation chemotherapeutic drugs. Still, despite its importance for genome stability and potential clinical impact, we know very little about how DSB repair pathway choice is executed. The goal of my research project in the Durocher lab at the Lunenfeld-Tanenbaum Research Institute is therefore to explore how cells choose between DSB repair pathways on the molecular level. Modern functional genomic approaches implemented in collaboration with other accomplished scientists in Toronto's research institutions will be used to screen among thousands of genes, in cultured human cells, for novel factors involved in DSB repair pathway choice. The factors will be identified based on a simple strategy that uses sensitivity to PARPi as readout. We will then characterize the biological functions of the newly identified factors to establish the molecular details of DSB repair pathway choice, expanding the understanding of how genome stability is regulated in normal as well as malignant cells.
Competitiondate
201409
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Zimmermann, Michal
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~